Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) FCF Margin (2020 - 2025)

Historic FCF Margin for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to 44.33%.

  • SOPHiA GENETICS's FCF Margin rose 82400.0% to 44.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 51.73%, marking a year-over-year increase of 191300.0%. This contributed to the annual value of 67.11% for FY2024, which is 145500.0% up from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's FCF Margin is 44.33%, which was up 82400.0% from 44.28% recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's FCF Margin registered a high of 44.28% during Q2 2025, and its lowest value of 190.4% during Q3 2022.
  • For the 5-year period, SOPHiA GENETICS's FCF Margin averaged around 98.24%, with its median value being 80.19% (2023).
  • Its FCF Margin has fluctuated over the past 5 years, first skyrocketed by 1434946700bps in 2021, then crashed by -466800bps in 2022.
  • Over the past 5 years, SOPHiA GENETICS's FCF Margin (Quarter) stood at 139.6% in 2021, then soared by 52bps to 67.62% in 2022, then fell by -8bps to 72.89% in 2023, then increased by 19bps to 59.03% in 2024, then rose by 25bps to 44.33% in 2025.
  • Its FCF Margin stands at 44.33% for Q3 2025, versus 44.28% for Q2 2025 and 60.21% for Q1 2025.